Skip to main content

Blavatnik Fund button The Blavatnik Fund for Innovation at Yale

Please meet all of our Blavatnik Awardees, and watch some of their winning pitch presentations. 

 

Jeffrey Bender, M.D.

Jeffrey Bender
Robert I. Levy Professor of Medicine (Cardiology) and Professor of Immunobiology; Associate Chief, Cardiovascular Medicine, Internal Medicine; Director, Yale Cardiovascular Research Center, Internal Medicine

TargaCept: An miRNA Target-based Oligonucleotide for the treatment of Uveitis and Other Inflamatory Disorders.

Anton Bennett, Ph.D.

Anton Headshot
Dorys McConnell Duberg Professor of Pharmacology and Professor of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs

Developing a chemical drug design platform to establish rich intellectual property for a first-in-class therapeutic for the treatment of fibrosis.

Ranjit S. Bindra, M.D., Ph.D.

Ranjit
Professor of Therapeutic Radiology

Athena Therapeutics: Targetting Cancer at its core.

Jonathan Bogan, M.D.

Jonathan Bogan headshot
Associate Professor of Medicine (Endocrinology) and of Cell Biology

Combatting Obesity through a novel mechanism.

Elliott Brown, M.D.

Elliott Brown headshot
Assistant Professor, Clinician Educator

A novel bone marrow aspiration device that limits blood contamination and maximizes stem cell recovery.

Sidi Chen, Ph.D.

Sidi Chen headshot
Assistant Professor

MAEGI Medicine: New Paradigm of Immune Gene Therapy.

John Deacon Ph.D.

John Deacon headshot
Associate Research Scientist

Cytosolics: Targeting Cancer Drugs.

Barbara Ehrlich, Ph.D.

Barbara Ehrlich headshot
Professor of Pharmacology and of Cellular And Molecular Physiology

NCS1 - A New Target for Wolfram Syndrome.

Jonathan Ellman, PhD

jonathan ellman
Eugene Higgins Professor of Chemistry and Professor of Pharmacology

A novel chemistry approach to target p53 mutation in human cancer. (Co-Pitch with Ya Ha, Ph.D.)

Michael Giradri, M.D., FAAD

Michael Girardi headshot
Professor of Dermatology; Dermatology; Director, Residency Program; Vice Chair; Director, T32 Research Fellowship Program

A multi-functional bioadhesive nanoparticle platform that has the potential to revolutionize the suncare industry.

Peter M. Glazer, M.D., Ph.D.

Peter Glazer headshot
Robert E. Hunter Professor of Therapeutic Radiology and Professor of Genetics; Chair, Department of Therapeutic Radiology

Antibody meditated Gene Editing.

Ya Ha, Ph.D.

Ya Ha headshot
Associate Professor of Pharmacology

A novel chemistry approach to target p53 mutation in human cancer. (Co-Pitch with Jonathan Ellman, PhD)

Akiko Iwasaki, Ph.D.

Akiko Iwasaki headshot
Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology; Professor of Molecular Cellular and Developmental Biology; Investigator, Howard Hughes Medical Institute

Cynaxis: Immunological Approach to Provide Drug Access to the CNS.

Naftali Kaminski, M.D.

Naftali Kaminski headshot
Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine (Pulmonary); Section Chief, Pulmonary, Critical Care & Sleep Medicine

Vittix Therapeutics: Curing Idiopathic Pulmonary Fibrosis with Thyroid Hormone Mimetics.

Mark A. Lemmon, Ph.D., FRS

Mark Lemmon
David A. Sackler Professor of Pharmacology; Associate Cancer Center Director for Basic Science, Yale Cancer Center; Co-director, Cancer Biology Institute

Drugging Fibrodysplasia Ossificans Progressiva. (Pitch By Ashtekar, Kumar)

Choukri Ben Mamoun, Ph.D.

Choukri Ben Mamoun headshot
Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis

EliV5: First in class Antifungal Agents.

Andrew Miranker, Ph.D.

Andrew Miranker headshot
Professor of Molecular Biophysics and Biochemistry and of Chemical and Environmental Engineering

Breaking toxin propagation in multiple system atrophy.

Anna M. Pyle, Ph.D.

Anna Pyle headshot
Sterling Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry; Director, Division of Biological Sciences

Intronistat Therapeutics: Nontoxic Antifungals That Target RNA.

Aaron Ring, M.D., Ph.D.

Aaron Ring headshot
Asst. Prof of Immunobiology

Breaking the Vicious Cycle of Inflammation and Cell Death in Sepsis.

W. Mark Saltzman, Ph.D.

Mark Saltzman headshot
Goizueta Foundation Professor of Biomedical Engineering, Chemical & Environmental Engineering & Physiology

A multi-functional bioadhesive nanoparticle platform.

Alanna Schepartz, Ph.D.

Alanna Schepartz headshot
Sterling Professor of Chemistry

Cell-Permeable Miniature Proteins:  Therapeutic proteins for all.

David Spiegel, M.D., Ph.D., A.B.

David Spiegel headshot
Professor of Chemistry

MODA Pharmaceuticals: Targeted Elimination Platform for Pathogenic Extracellular Proteins.

Stephen Strittmatter, M.D., Ph.D.

Stephen Strittmatter headshot
Vincent Coates Professor of Neurology and Professor of Neuroscience; Director, Cellular Neuroscience, Neurodegeneration and Repair; Director, Memory Disorders Clinic; Director, Yale Alzheimer’s Disease Research Center

Developing select inhibitors to slow, halt or reverse the course of Alzheimer’s disease.

Andrew Xiao, Ph.D.

Andrew Xiao headshot
Associate Professor Tenure

Developing therapeutics around a novel epigenetic mechanism aimed at end-stage tumors.